Literature DB >> 23721273

Screening for cervical cancer in low-resource settings in 2011.

Rosemary Tambouret1.   

Abstract

CONTEXT: Cervical cancer remains the most common malignancy in women living in low- and middle-income countries, despite the decline of the disease in countries where cervical cytology screening programs have been implemented.
OBJECTIVES: To review the current incidence of cervical cancer in low-resource countries, the availability and types of screening programs, and the treatment options. DATA SOURCES: Literature review through PubMed, Internet search, and personal communication.
CONCLUSIONS: Although data are incomplete, available figures confirm that the rate of cervical cancer deaths and the availability of cervical cancer screening programs are inversely proportional and vary, in general, by the wealth of the nation. Despite the success of cervical cytology screening, many major health care organizations have abandoned screening by cytology in favor of direct visualization methods with immediate treatment of lesions by cryotherapy provided by trained, nonmedical personnel.

Entities:  

Mesh:

Year:  2013        PMID: 23721273     DOI: 10.5858/arpa.2011-0695-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

1.  Utilisation of Community Audio Towers in Health Education for Prevention of Cervical Cancer by Health Workers in Kyotera District, Uganda: A Cross-Sectional Study.

Authors:  Richard Kabanda; Everd Bikaitwoha Maniple; Joseph Baruch Baluku; Arthur Kiconco
Journal:  Risk Manag Healthc Policy       Date:  2021-09-01

Review 2.  Role of colposcopy in the management of women with abnormal cytology.

Authors:  Roopa Hariprasad; Srabani Mittal; Partha Basu
Journal:  Cytojournal       Date:  2022-06-14       Impact factor: 2.345

3.  Introduction of p16INK4a as a surrogate biomarker for HPV in women with invasive cervical cancer in Sudan.

Authors:  Hina Sarwath; Devendra Bansal; Nazik Elmalaika Husain; Mahmoud Mohamed; Ali A Sultan; Shahinaz Bedri
Journal:  Infect Agent Cancer       Date:  2017-09-30       Impact factor: 2.965

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.